Lymphoma Neoplasms
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study to Assess Mass Balance, Pharmacokinetics (PK), and Metabolism of Orally Administered [14 C]-TAK-659 in Participants With Advanced Solid Tumor and/or Lymphoma Malignancies (NCT03338881) | Calithera Biosciences, Inc | 2018-05-10 |
Track Lymphoma Neoplasms automatically
Every clearance here is in the API, with alerts when new ones post.